讨论
F1watch2023-12-14 04:20
F-1/A - BioLingus (Cayman) Ltd (0001966522) (Filer) Filed: 2023-12-13 AccNo: 0001493152-23-044684 Size: 23 MB 网页链接查看全文
简介：BioLingus (Cayman) Limited是一家于2018年8月8日注册成立的控股公司，没有实质性业务。BioLingus是一家根据开曼群岛法律注册成立的有限责任豁免公司，其主要业务是通过在瑞士的子公司进行的，其次是中华人民共和国和澳大利亚的子公司。该公司是一家生物技术公司，率先开发口服（特别是舌下）递送肽和蛋白质。
| 今开： | 昨收： |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值： |
F1watch2023-12-14 04:20
F-1/A - BioLingus (Cayman) Ltd (0001966522) (Filer) Filed: 2023-12-13 AccNo: 0001493152-23-044684 Size: 23 MB 网页链接查看全文
F1watch2023-11-10 06:40
F-1/A - BioLingus (Cayman) Ltd (0001966522) (Filer) Filed: 2023-11-09 AccNo: 0001493152-23-040135 Size: 23 MB 网页链接查看全文
F1watch2023-07-28 00:20
F-1/A - BioLingus (Cayman) Ltd (0001966522) (Filer) Filed: 2023-07-27 AccNo: 0001493152-23-025645 Size: 4 MB 网页链接查看全文
F1watch2023-07-13 23:40
F-1/A - BioLingus (Cayman) Ltd (0001966522) (Filer) Filed: 2023-07-13 AccNo: 0001493152-23-024425 Size: 23 MB 网页链接查看全文
$BioLingus(SUBL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000258 Act: 33 Size: 1 KB 网页链接
$BioLingus(SUBL)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001493152-23-045393 Act: 33 Size: 23 MB 网页链接
$BioLingus(SUBL)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001493152-23-044684 Act: 33 Size: 23 MB 网页链接
$BioLingus(SUBL)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001493152-23-040135 Act: 33 Size: 23 MB 网页链接
$BioLingus(SUBL)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001493152-23-025645 Act: 33 Size: 4 MB 网页链接
$BioLingus(SUBL)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001493152-23-024425 Act: 33 Size: 23 MB 网页链接
$BioLingus(SUBL)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001493152-23-023168 Act: 33 Size: 23 MB 网页链接